WFG Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$889K Sell
11,047
-1,420
-11% -$112K 0.2% 119
2017
Q1
$979K Buy
12,467
+538
+5% +$43K 0.26% 89
2016
Q4
$941K Buy
11,929
+3,092
+35% +$250K 0.23% 108
2016
Q3
$786K Sell
8,837
-1,826
-17% -$172K 0.2% 124
2016
Q2
$1.02M Buy
10,663
+509
+5% +$50.7K 0.27% 96
2016
Q1
$1.05M Sell
10,154
-182
-2% -$17.7K 0.3% 80
2015
Q4
$1.01M Sell
10,336
-342
-3% -$33.5K 0.3% 74
2015
Q3
$1.03M Sell
10,678
-933
-8% -$98.1K 0.32% 72
2015
Q2
$1.22M Buy
11,611
+3,407
+42% +$348K 0.34% 64
2015
Q1
$847K Sell
8,204
-1,333
-14% -$135K 0.24% 96
2014
Q4
$919K Buy
9,537
+669
+8% +$58.9K 0.19% 123
2014
Q3
$706K Buy
8,868
+297
+3% +$23.4K 0.13% 185
2014
Q2
$646K Buy
8,571
+1,081
+14% +$81.7K 0.12% 204
2014
Q1
$561K Sell
7,490
-92
-1% -$6.5K 0.11% 214
2013
Q4
$543K Buy
7,582
+2,248
+42% +$144K 0.08% 293
2013
Q3
$303K Buy
5,334
+1,106
+26% +$65.9K 0.05% 387
2013
Q2
$242K Buy
+4,228
New +$245K 0.04% 418

Other funds holding CVS

WFG Advisors's CVS Position: Q2 2017 in Review

WFG Advisors reduced its CVS Health (CVS) stake by 11% in Q2 2017, selling an estimated $112K and leaving 11,047 shares worth $889K. The position accounts for 0.2% of the portfolio, ranked #119.

WFG Advisors first reported a position in CVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.22M in Q2 2015. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • WFG Advisors held 11,047 shares of CVS Health worth $889K as of Q2 2017.
  • WFG Advisors sold 1,420 CVS Health shares in Q2 2017, an estimated $112K.
  • CVS Health made up 0.2% of WFG Advisors's portfolio in Q2 2017, its #119 holding.
  • WFG Advisors first reported a position in CVS Health in Q2 2013 and has held it in 17 quarters since.
  • WFG Advisors's CVS Health position peaked at $1.22M in Q2 2015.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.